Industry collaborations advancing drug discovery
Drug Discovery World
MARCH 22, 2023
It will combine the use of novel Huntington’s disease drug targets from Aitia’s Gemini Digital Twins with UCB’s expertise in drug research and preclinical model systems in neurodegeneration, with the aim to accelerate the discovery of new therapies for people living with Huntington’s disease.
130 
Let's personalize your content